Sarilumab (Kevzara)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sarilumab (Kevzara), covering 2016-04-07 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI [Phase 2, Phase 3]